US President Donald Trump has abruptly stopped funding the President’s Emergency Plan for AIDS Relief (PEPFAR), causing significant disruptions to global HIV/AIDS programmes.
Since 2003, PEPFAR has invested more than $85 billion in the global fight against HIV/AIDS, saving over 17 million lives across 54 countries.
In Nigeria, the U.S. government has invested over $6 billion into the national HIV/AIDS response, significantly improving the country’s efforts to combat the epidemic.
However, recent developments have raised serious concerns about the future of Nigeria’s HIV/AIDS programs. According to a source at the Institute of Human Virology Nigeria (IHVN), the Trump administration’s 90-day freeze on foreign aid could spell trouble for the country.
The Guardian reports a source that PEPFAR has been gradually scaling down its involvement in Nigeria in recent years. The organisation expects the Nigerian government to take over HIV/AIDS and malaria programs. However, the Nigerian government’s failure to fully assume responsibility for these critical programs has reduced U.S. support, including dwindling supplies and less funding.
“With the ongoing reduction in funding and resources, if the U.S. pulls its remaining support, we will be in serious trouble. The progress we’ve made so far could be jeopardised,” the source explained.
U.S. Embassy and Consulate in Nigeria, PEPFAR, has played a pivotal role in ensuring that over 1 million women and children in Nigeria are currently receiving life-saving HIV treatment.
The program’s success has been instrumental in reducing the number of new infections and providing care to millions who would otherwise have no access to treatment.
However, as outlined in a memo received by U.S. diplomats, the 90-day pause on foreign aid applies to new and existing funding, including ongoing HIV/AIDS programs.
The directive, part of Trump’s executive order on foreign aid, has surprised and concerned many U.S. diplomats and public health experts.
As Nigeria continues to face challenges in taking full ownership of its HIV/AIDS response, experts worry that any further reduction in U.S. support will significantly harm efforts to control the epidemic, putting millions of lives at risk.
